Analysis of factors influencing the readiness for coronavirus vaccination: results of a survey of HIV-infected patients


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To investigate the factors influencing the readiness of HIV-infected patients to be vaccinated against coronavirus infection in order to clarify measures aimed at preventing COVID-19 infection. Subjects and methods. The investigation conducted in the period February 9 to March 26, 2021, which involved 113 HlV-infected patients registered in the Specialized Research Department of AIDS Epidemiology and Prevention, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being. The questionnaire method was used. Results. 32.7% of the respondents expressed more likely a positive attitude to vaccination. A total of 23.9% of the respondents rated their coronavirus vaccination awareness as high as possible. Their readiness for vaccination was higher than that in respondents with low awareness (40.7 and 12.5%, respectively; p = 0.017). The information obtained from the attending physician (63.7%) was the most trusted when making a decision on vaccination in the surveyed group. 24.3% of the survey participants showed the maximum interest in obtaining information. 47.1% of them displayed their readiness for vaccination; 23.5% were unready for the latter. Conclusion. The results of the study could identify the factors influencing the patient’s decision to be vaccinated against COVID-19, which should be taken into account when advising on vaccination issues.

全文:

受限制的访问

作者简介

Ulyana Kuimova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: ulyanakuimova@gmail.com
Cand. Med. Sci., Researcher

Valentina Belyaeva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: labora-et-ora@yandex.ru
МБ, Leading Researcher

Nadezhda Kozyrina

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: nad-kozyrina@yandex.ru
Cand. Med. Sci., Researcher

Ekaterina Kulabukhova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; Peoples' Friendship University of Russia

Email: ekulabukhova@mail.ru
Infectiologist

Marina Goliusova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: mad2501@yandex.ru
Infectiologist

Artem Narkevich

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia

Email: narkevichart@gmail.com
МD, Associate Professor, Head, Department of Medical Cybernetics and Informatics, Head, Laboratory of Medical Cybernetics and Management in Healthcare

参考

  1. Актуальная эпидемическая ситуация в России и мире 2021 год. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. https://www.rospotrebnadzor.ru/region/korono_virus/epid.php
  2. Ладная Н.Н., Козырина Н.В., Бабихина К.А., Михайлов А.В., Годлевская М.В., Егорова Н.В. и др. Результаты исследования «Изучение распространенности коронавирусной инфекции COVID-19 среди инфицированных ВИЧ пациентов в России и влияния эпидемии коронавирусной инфекции COVID-19 на оказание медицинской помощи при ВИЧ-инфекции». dannye-issledovaniya-vich-i-sovid-19.pdf
  3. Кравченко А.В., Куимова У.А., Голиусова М.Д., Козырина Н.В., Кулабухова Е.И. Особенности течения коронавирусной инфекции у больных ВИЧ-инфекцией. Материалы Российской научно-практической конференции «Управляемые и другие социально-значимые инфекции: диагностика, лечение и профилактика». Спб., 3-4 февраля 2021 г. Журнал Инфектологии 2021; 13(1, приложение 1): 70-71.
  4. Hoffmann C., Casado J.L., Harter G., Vizcarra P., Moreno A., Cattaneo D. et al. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med. 2021; 22(5): 372-78. doi: 10.1111/hiv.13037.
  5. Del Amo J., Polo R., Moreno S., Diaz A., Martinez E., Arribas J.R. et al.; The Spanish HIV/COVID-19 Collaboration. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study. Ann. Intern. Med. 2020; 173: 536-41.
  6. Правила профилактики новой коронавирусной инфекции. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. https: //www. rospotrebnadzor.ru/about/info/news_time/news_details.php
  7. Вакцина для профилактики COVID-19. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. https://www.rospotrebnadzor.ru/region/korono_virus/versuscovid.php
  8. People with Certain Medical Conditions. Centers for desease control and prevention. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html
  9. Guidance for COVID-19 and People with HIV. https://clinicalinfo.hiv.gov/en/guidelines/covid-19-and-persons-hiv-interim-guidance/interim-guidance-covid-19-and-persons-hiv
  10. Вакцины от COVID-19 при ВИЧ. https://www.unaids.org/ru/resources/documents/2021/covid19-vaccines-and-hiv
  11. Вакцинация: ключ на старт! Аналитический обзор. M.: ВЦИОМ, 2020. https://wciom.ru/analytical-reviews/analiticheskii-obzor/vakcinacija-kljuch-na-start

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2021
##common.cookie##